Form 8-K - Current report:
SEC Accession No. 0001193125-21-109624
Filing Date
2021-04-08
Accepted
2021-04-08 08:33:02
Documents
15
Period of Report
2021-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d114545d8k.htm   iXBRL 8-K 32236
2 EX-4.1 d114545dex41.htm EX-4.1 78130
3 EX-10.1 d114545dex101.htm EX-10.1 109869
4 EX-10.2 d114545dex102.htm EX-10.2 45889
  Complete submission text file 0001193125-21-109624.txt   452295

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cydy-20210402.xsd EX-101.SCH 3066
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20210402_lab.xml EX-101.LAB 16083
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20210402_pre.xml EX-101.PRE 10118
8 EXTRACTED XBRL INSTANCE DOCUMENT d114545d8k_htm.xml XML 3002
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 21813847
SIC: 2834 Pharmaceutical Preparations